Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus

The identification of patients with advanced fibrosis who do not need any further hepatocellular carcinoma (HCC) surveillance after the eradication of hepatitis C is pivotal. In this study, we developed a simple serum‐based risk model that could identify patients with low‐risk HCC. This was a nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamaki, Nobuharu, Kurosaki, Masayuki, Yasui, Yutaka, Mori, Nami, Tsuji, Keiji, Hasebe, Chitomi, Joko, Kouji, Akahane, Takehiro, Furuta, Koichiro, Kobashi, Haruhiko, Kimura, Hiroyuki, Yagisawa, Hitoshi, Marusawa, Hiroyuki, Kondo, Masahiko, Kojima, Yuji, Yoshida, Hideo, Uchida, Yasushi, Tada, Toshifumi, Nakamura, Shinichiro, Yasuda, Satoshi, Toyoda, Hidenori, Loomba, Rohit, Izumi, Namiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870028/
https://www.ncbi.nlm.nih.gov/pubmed/34676692
http://dx.doi.org/10.1002/hep4.1833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870028/
https://www.ncbi.nlm.nih.gov/pubmed/34676692
http://dx.doi.org/10.1002/hep4.1833

Ejemplares similares